Search for:
Category

Regulatory

Category

The Digital-Supply-Act (Digitale-Versorgung-Gesetz, “DVG”), which aims to further promote digitization in the German health care system, entered into force on 19 December 2019 and regulates, inter alia, the prescription of Digital Health Apps by HCPs (including the cost bearing by statutory health insurance). Patients insured with statutory health funds are eligible for reimbursement of Digital Health Apps. As of this August, prescription for Digital Health Apps will be available, according to statements made by the Federal Ministry of Health at an event of the Health Innovation Hub on 16th July 2020.

There is no denying we were all caught off-guard by the speed and force with which COVID-19 struck every aspect of Australian life. As some parts of the country slowly begin to emerge from COVID-19 restrictions (albeit uncertainly), our attention inevitably turns to the question: “what can we learn for next time?”

Many sentimental answers are sure to be proffered by feel-good television specials over the coming months. While we won’t claim to be experts in “feel-good”, here in the employment team at Baker McKenzie, what we have become well-versed in is the range of practical challenges that COVID-19 has posed to our clients as they have attempted to manage their workforce through this time of change.

With that in mind, we have set out below our tips to help ensure your organisation is best prepared for whatever the next COVID-19 may be.

In a judgment delivered on 9 July 2020, the CJEU held that a new therapeutic application for an authorised medicinal product cannot be the subject of a supplementary protection certificate (SPC).  This clarifies the position on an issue that has been unclear for nearly a decade, but will be unwelcome to companies in the healthcare and life sciences sector who have invested, and continue to invest, in the development of new therapeutic applications for authorised products. It will have a significant impact on pending SPC applications relating to second medical uses.

The second package of tax measures for supporting the Italian economy in the context of the COVID-19 outbreak has finally been approved. Indeed, Law Decree No. 34 dated 19 May 2020 (“Rilancio Decree”) was converted into Law No. 77 on 17 July 2020, with a few amendments with respect to the prior version (which are highlighted in bold).

Beneficial tax measures helping individual and companies to face the COVID-19 outbreak will be commented upon therein, while tax incentives and measures affecting tax litigation activities will be explored in separate follow-up alerts.

The Rilancio Decree came into effect on 19 May 2020, while the amendments made at the time of the conversion into law highlighted in bold took effect from 19 July 2020.

The second package of tax measures for supporting the Italian economy in the context of the COVID-19 outbreak has finally been approved. Indeed, Law Decree No. 34 dated 19 May 2020 (“Rilancio Decree”) was converted into Law No. 77 on 17 July 2020, with a few amendments with respect to the prior version (which are highlighted in bold).

Tax incentives helping individuals and companies to face the COVID-19 outbreak will be commented therein, while beneficial tax measures and measures affecting tax litigation activities will be explored in separate follow-up alerts.

The Rilancio Decree came into effect on 19 May 2020, while the amendments made at the time of the conversion into law — highlighted in bold — took effect from 19 July 2020. 

Overview The Alien Tort Statute (“ATS”) has been the subject of several US Supreme Court decisions over the past decade.   To summarize its long and complicated past, the ATS is a statute that gives US federal courts jurisdiction to hear lawsuits filed by non-US citizens for torts committed in violation…

The COVID-19 pandemic has disrupted the supply of essential goods and services around the world, including Singapore, and such disruptions have required competitors to temporarily collaborate to sustain or improve the supply of essential goods and services. To provide clarity on whether such collaborations will fall afoul of the Singapore Competition Act (Cap. 50B) (the “Act”), the Competition and Consumer Commission of Singapore (“CCCS”) has issued the “CCCS Guidance Note on Collaborations between Competitors in Response to the COVID-19 Pandemic” (“Guidance Note”).

Please join us for a new weekly video series, hosted by Baker McKenzie’s North America Government Enforcement partners Tom Firestone and Jerome Tomas.

This weekly briefing is available on demand and will cover hot topics and current enforcement actions related to white collar crime and criminal investigations in the US and abroad to arm you with the information you need to start your business week.

As one of the largest global law firms, we will call upon our exceptionally deep and broad bench of white collar experts throughout the world and particularly in the commercial hubs of Europe, Asia, Africa and Latin America to join our weekly discussion series.

In brief The European Commission (Commission) has launched a sector inquiry into the market for consumer products and services linked to the Internet of Things (IoT). This marks the start of an intensive information gathering process in which hundreds of companies will be asked for information about the products they…